Showing results (91-100 of 97) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Journal of Affective Disorders|May 29, 2025
Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS studyMary Lou Chatterton, Johana Kevin Perez, Thao Thai, et al.Community Genetics|June 19, 2007
Report of an international survey of molecular genetic testing laboratoriesMargaret M McGovern, Rob Elles, Isabella Beretta, et al.The British Journal of Psychiatry : the Journal of Mental Science|July 6, 2026
Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS studyNick Glozier, Richard Morris, Elizabeth Stratton, et al.JAMA Neurology|November 4, 2024
Deferiprone in Alzheimer Disease: A Randomized Clinical TrialScott Ayton, David Barton, Bruce Brew, et al.The British Journal of Psychiatry : the Journal of Mental Science|December 18, 2023
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trialColleen Loo, Nick Glozier, David Barton, et al.The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trialStephen Macfarlane, Timo Grimmer, Ken Teo, et al.The New England Journal of Medicine|January 26, 2017
Genetic Drivers of Kidney Defects in the DiGeorge SyndromeEsther Lopez-Rivera, Yangfan P Liu, Miguel Verbitsky, et al.Pageof 10